Evidence map›Paper›PMID 38282667›Full record

ArticlePreventive medicine reports2024

Assessing the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults: A cross-sectional study.

Mohamad Klib, Osama Alazki, Ayman Issa Nabhan, Aml M Brakat, Bana Zuhair Alafandi, Fatima Abdulmoain Idres, Ruba Almenchaf, Farah Albakkar, Munir Ghandour, Jaafar Zahlout and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Preventive medicine reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohamad KlibFaculty of Medicine, Damascus University, Damascus, Syria.
Osama AlazkiFaculty of Medicine, Tishreen University, Latakia, Syria.
Ayman Issa NabhanFaculty of Medicine, Al Andalus University for Medical Sciences, Tartus, Syria.
Aml M BrakatFaculty of Medicine, Zagazig University, Ash Sharqia Governorate ,Egypt.
Bana Zuhair AlafandiFaculty of Medicine, University of Aleppo, Aleppo, Syria.
Fatima Abdulmoain IdresFaculty of Medicine, AL-Baath University, Homs, Syria.
Ruba AlmenchafFaculty of Medicine, AL-Baath University, Homs, Syria.
Farah AlbakkarFaculty of Medicine, University of Aleppo, Aleppo, Syria.
Munir GhandourFaculty of Medicine, Damascus University, Damascus, Syria.
Jaafar ZahloutFaculty of Medicine, Tishreen University, Latakia, Syria.
Somayya TabshoFaculty of Medicine, University of Aleppo, Aleppo, Syria.
Samar MouazenFaculty of Medicine, Damascus University, Damascus, Syria.
Data Collection Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study aimed to assess the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults, with a focus on the AstraZeneca and Sputnik Light vaccines, in light of the low vaccination rate in Syria (below 18%) attributed to fear of side effects. Method: A cross-sectional study was conducted between January and May 2022, using probability-based and convenient sampling strategies. Data was collected through online, paper, and face-to-face questionnaires that included demographic and vaccine-related questions. Result: Out of 3,766 participants, the majority were female (56.7 %) and aged 18-24 years (53.3 %). Most participants had a university-level qualification (71.2 %) and were related to the medical sector (53.2 %). A significant proportion (47.0 %) received AstraZeneca, Sputnik Light (22.1 %) and Sinopharm (14.7 %). Common side effects included sleepiness and lethargy (50.0 %), fever and chills (45.0 %), and pain/swelling at the injection site (35.9 %). Multivariate logistic regression analysis revealed that male (OR: 0.57, CI: 0.48-0.68) and participants aged 45-65 years (OR: 0.53, CI: 0.40-0.70) were less likely to experience side effects. Participants who believed COVID-19 posed a high threat to their personal life had higher odds of side effects (OR: 1.74, CI: 1.22-2.46). Vaccine type was also associated with side effects, with Sputnik Light (OR: 2.52, CI: 1.85-3.46) and AstraZeneca (OR: 1.61, CI: 1.26-2.05) having increased odds. Conclusion: Our study found that COVID-19 vaccines are well tolerated among the Syrian population, with short-term side effects that typically resolve within three days. These findings are expected to bolster vaccination rates through enhanced public confidence and acceptance.

Indexed as

AstraZenecaCOVID-19FeverLethargySide effectSleepinessSputnik LightVaccine

Identifiers

PMID38282667
PMCPMC10810828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.